The University of Chicago Header Logo

Connection

Gladell Paner to Urinary Bladder Neoplasms

Back to Details
This is a "connection" page, showing publications Gladell Paner has written about Urinary Bladder Neoplasms.
Gladell Paner
Connection Strength
9.983
Urinary Bladder Neoplasms
  1. The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Glandular Lesions of the Urinary Bladder. Adv Anat Pathol. 2026 Jan 01; 33(1):1-16.
    View in: PubMed
    Score: 0.700
  2. Glandular Lesions of the Urinary Bladder: Diagnostic and Molecular Updates. Adv Anat Pathol. 2024 Mar 01; 31(2):88-95.
    View in: PubMed
    Score: 0.631
  3. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas. Am J Surg Pathol. 2024 Jan 01; 48(1):e11-e23.
    View in: PubMed
    Score: 0.605
  4. Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice. Mod Pathol. 2022 10; 35(10):1296-1305.
    View in: PubMed
    Score: 0.558
  5. Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies. Hum Pathol. 2020 12; 106:54-61.
    View in: PubMed
    Score: 0.500
  6. Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79:82-104: Importance of Standardized Pathology Reporting for Urological Cancers in the Implementation of Urology Guidelines. Eur Urol. 2021 01; 79(1):e30-e32.
    View in: PubMed
    Score: 0.497
  7. Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion. Am J Surg Pathol. 2019 04; 43(4):475-479.
    View in: PubMed
    Score: 0.451
  8. Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections. Arch Pathol Lab Med. 2019 12; 143(12):1562-1567.
    View in: PubMed
    Score: 0.449
  9. Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios. Surg Pathol Clin. 2018 Dec; 11(4):775-795.
    View in: PubMed
    Score: 0.441
  10. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances. Adv Anat Pathol. 2017 May; 24(3):113-127.
    View in: PubMed
    Score: 0.395
  11. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin. Adv Anat Pathol. 2016 Mar; 23(2):71-83.
    View in: PubMed
    Score: 0.364
  12. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder. Am J Surg Pathol. 2014 Sep; 38(9):1251-9.
    View in: PubMed
    Score: 0.328
  13. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Hum Pathol. 2014 Jul; 45(7):1473-82.
    View in: PubMed
    Score: 0.318
  14. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Am J Surg Pathol. 2012 Mar; 36(3):432-42.
    View in: PubMed
    Score: 0.276
  15. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol. 2011 Jun; 35(6):787-98.
    View in: PubMed
    Score: 0.262
  16. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol. 2011 Jan; 18(1):79-89.
    View in: PubMed
    Score: 0.255
  17. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens. Am J Surg Pathol. 2010 Jun; 34(6):792-9.
    View in: PubMed
    Score: 0.244
  18. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2009 Jan; 33(1):91-8.
    View in: PubMed
    Score: 0.222
  19. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol. 2008 Jul; 32(7):1022-8.
    View in: PubMed
    Score: 0.214
  20. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2007 Sep; 31(9):1420-9.
    View in: PubMed
    Score: 0.202
  21. International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder. Am J Surg Pathol. 2025 Dec 01; 49(12):e46-e57.
    View in: PubMed
    Score: 0.174
  22. Urothelial carcinoma in situ with "early papillary formation" vs "lateral spread/shoulder lesion" of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations. Am J Clin Pathol. 2025 Apr 19; 163(4):629-640.
    View in: PubMed
    Score: 0.171
  23. Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study. Histopathology. 2025 Nov; 87(5):649-659.
    View in: PubMed
    Score: 0.170
  24. Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature. Histopathology. 2024 Nov; 85(5):748-759.
    View in: PubMed
    Score: 0.163
  25. Giant cell carcinoma of the urinary bladder : Clinicopathologic analysis and oncological outcomes. Virchows Arch. 2024 Sep; 485(3):535-546.
    View in: PubMed
    Score: 0.163
  26. Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma. Int J Surg Pathol. 2020 Feb; 28(1):51-59.
    View in: PubMed
    Score: 0.116
  27. Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J Urol. 2019 Jan; 37(1):107-114.
    View in: PubMed
    Score: 0.108
  28. Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer. Cancer Immunol Res. 2016 07; 4(7):563-8.
    View in: PubMed
    Score: 0.092
  29. Urinary bladder xanthoma: a multi-institutional series of 17 cases. Histopathology. 2015 Aug; 67(2):255-61.
    View in: PubMed
    Score: 0.085
  30. Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Mod Pathol. 2015 May; 28(5):612-30.
    View in: PubMed
    Score: 0.083
  31. Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists. Am J Surg Pathol. 2014 Feb; 38(2):167-75.
    View in: PubMed
    Score: 0.079
  32. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Am J Surg Pathol. 2013 Dec; 37(12):1876-81.
    View in: PubMed
    Score: 0.078
  33. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence. Ann Diagn Pathol. 2014 Apr; 18(2):49-52.
    View in: PubMed
    Score: 0.078
  34. The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling. Hum Pathol. 2013 Aug; 44(8):1605-11.
    View in: PubMed
    Score: 0.074
  35. Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases. Hum Pathol. 2013 May; 44(5):860-6.
    View in: PubMed
    Score: 0.073
  36. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. J Urol. 2013 Jan; 189(1):53-8.
    View in: PubMed
    Score: 0.072
  37. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. Eur Urol. 2013 Jan; 63(1):16-35.
    View in: PubMed
    Score: 0.072
  38. Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula. Hum Pathol. 2011 Nov; 42(11):1770-6.
    View in: PubMed
    Score: 0.067
  39. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol. 2010 Sep; 34(9):1367-76.
    View in: PubMed
    Score: 0.062
  40. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol. 2009 Jan; 33(1):99-105.
    View in: PubMed
    Score: 0.055
  41. A carcinosarcoma/sarcomatoid carcinoma arising in a urinary bladder diverticulum. Arch Pathol Lab Med. 2002 Jul; 126(7):853-5.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.